Magnesium therapy for torsades de pointes.

Area of Science:

• Cardiology
• Pharmacology

Background:

• Torsades de pointes (TdP) is a life-threatening ventricular arrhythmia.
• TdP can be drug-induced or associated with prolonged QT intervals.
• Established treatments for TdP can have limitations or contraindications.

Observation:

• Three patients presented with TdP, induced by various medications (quinidine/amiodarone, procainamide, imipramine overdose).
• Prolonged QT intervals were noted prior to TdP episodes.
• Intravenous magnesium sulfate (MgSO4) was administered as a bolus and, in one case, with a continuous infusion.

Findings:

• A bolus of 1.0-2.0 g MgSO4 successfully abolished TdP in all three patients.
• Recurrent TdP in one patient was managed with a second bolus and a 24-hour infusion.
• No immediate QT interval shortening was observed post-MgSO4 administration.

Implications:

• Magnesium sulfate represents a safe and effective treatment for TdP, even in patients with contraindications to other therapies.
• MgSO4 administration is faster than temporary cardiac pacing.
• Further clinical trials investigating magnesium sulfate for TdP are warranted.